March 9, 2015

University of Pittsburgh School of Pharmacy created a site to address state-wide addiction problem. 

March 6, 2015

CVS Health's chief medical officer is addressing the National Business Group on Health.

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 5, 2015

CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).

March 5, 2015

McKesson Care Management has been recognized for its processes, quality program and reporting, and care management electronic capture system.

March 4, 2015

Miraculins in January announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario beginning in February.

March 4, 2015

In a meeting with nearly two dozen leaders representing consumers, insurers, providers and business leaders, Health and Human Services Secretary Sylvia Burwell on Jan. 26 announced measurable goals and a timeline to move the Medicare program, and the healthcare system at large, toward paying providers based on the quality of care they give patients.

March 4, 2015

The introduction in January of bipartisan legislation that would grant retail pharmacists provider status for Medicare patients in “underserved” communities certainly sounds like a step in the right direction.

March 4, 2015

The brand's latest survey was designed to help understand the impact of the common cold and/or flu at the individual level.

 

March 4, 2015

Pharmacy Quality Alliance and AllazoHealth announced the formation of a formal research partnership to study and improve medication adherence metrics.

 

March 3, 2015

Researchers have assessed the relationship between changes in a person’s activation level and changes in health outcomes and cost.

March 3, 2015

Healthcare systems should increasingly focus on digital technology as tech-savvy seniors seek more online options to access healthcare services from their home, according to a recent survey.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

March 2, 2015

Pain is proving to be a significant factor when it comes to sleeping patterns of Americans, according to a new poll by the National Sleep Foundation. Those suffering with chronic pain reported an average 42 minute sleep debt, whereas Americans who have experienced acute pain within the past week report a deficit of 14 minutes.

 

February 27, 2015

ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.

February 27, 2015

Remedies for conditions like hepatitis C, NASH (nonalcoholic steatohepatitis) and oncology will all help contribute to growth within the biotech sector, according to an analysis from Bloomberg Intelligence. 

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 27, 2015

Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends. 

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products.